The formulation of ophthalmic drugs must address a unique combination of requirements. In addition to ensuring quality, drug tolerability, and fostering patient compliance, formulators must also consider tonicity, viscosity, pH, stability, sterility, and microbiological purity. This webinar will address how to overcome common challenges in ophthalmic formulations with a selection of the right quality of excipients. Our GMP grade excipients are in line with ophthalmic industry standards and needs supported by our Emprove® Program. Our Emprove® Program along with the Emprove® Expert portfolio range combines comprehensive documentation with excellent service to support risk assessment and qualification for your ophthalmic process.
In this webinar, you will learn:
- Challenges in ophthalmic formulation development
- Selection of excipients for ophthalmic formulations
- Risk Mitigation in ophthalmic formulations with Emprove® Program
Speaker
Smita Rajput, Ph.D.
MilliporeSigma
Field Marketing Manager
Smita Rajput has a total of 8 years of experience in pharmaceutical product development. She is currently working as a field marketing manager for India, South East Asia, and Oceania.
Her expertise is in formulation development of complex injectable & ophthalmic segments, can direct users for selection of excipients. She has five patents and seven international publications in different complex formulation areas. She has professional experience with Dr. Reddy’s, Cadila Healthcare, and Johnson & Johnson.
Pharma and biopharma manufacturing
- Classical pharma manufacturing
Durée:1h
Langue:English
Session 1:présenté(e) September 20, 2022
Pour continuer à lire, veuillez vous connecter à votre compte ou en créer un.
Vous n'avez pas de compte ?